Daily News and Research on Pharmaceutical Stocks (10/15/2008)
Below is today's Daily News and Research on Pharmaceutical Stocks. Click here for historical daily updates.
ABT: Abbott Earnings Call scheduled for 9:00 am ET today - CCBN (Wed 9:00am)
ABT: Abbott posts higher profit, raises forecast - at MarketWatch (Wed 8:54am)
ABT: Abbott 3Q profit jumps, outlook boosted - AP (Wed 8:49am)
ABT: ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib - EDGAR Online (Wed 8:48am)
ABT: Abbott Labs profit soars 51 percent, raises forecast - Reuters (Wed 8:11am)
ABT: UPDATE - Abbott Labs profit soars 51 pct, raises forecast - at Reuters (Wed 8:04am)
ABT: Abbott earnings per share up 50% in quarter - at MarketWatch (Wed 7:40am)
ABT: InPlay: Abbott Labs beats by $0.02, beats on revs; guides FY08 EPS above consensus - Briefing.com (Wed 7:28am)
ABT: Abbott Reports Strong Sales and Earnings Growth in Third Quarter; Again Raises Full-Year Earnings Outlook - PR Newswire (Wed 7:24am)
ABT: Q3 2008 Abbott Earnings Release - Before Market Open - CCBN (Wed 7:07am)
ABT: STOCK PICKS: Top 5 Large-Caps for Oct. 15 - at TheStreet.com (Wed 6:55am)
ABT BMY JNJ: Abbott: Progress on Dissolving Stent - at BusinessWeek (Wed 8:08am)
DAILY NEWS & RESEARCH ON HEALTH CARE STOCKS - Click here
AGN: Allergan, Inc. and Clinique Announce Nationwide Availability of CLINIQUE MEDICAL - Business Wire (Wed 9:00am)
AUXL: Auxilium Pharmaceuticals, Inc. Earnings Call scheduled for Wed, Oct 29 - CCBN (Wed 9:10am)
AUXL: Auxilium Pharmaceuticals to Announce Third Quarter 2008 Results and Conduct Conference Call on Wednesday, October 29, 2008 - Marketwire (Wed 7:00am)
BMY: UPDATE - Glaxo expands in Egypt with $210 mln acquisition - at Reuters (Wed 6:12am)
CRL: Charles River Expands Global Footprint with Shanghai Facility Opening - Business Wire (Wed 8:30am)
DNA: Ahead of the Bell: Genentech - AP (Wed 7:31am)
DNA JNJ: Analysts' Upgrades, Downgrades: Dell - at TheStreet.com (Wed 9:10am)
GENZ: Genzyme Begins Enrollment in Post-Marketing Study to Evaluate Use of Low Dose Fabrazyme Treatment for Fabry Disease - Business Wire (Wed 8:33am)
IVGN: Invitrogen and Applied Biosystems Amend Merger Agreement to Eliminate Tax Opinion Condition; Stockholder Meetings to Be Moved to October 28, 2008 - Business Wire (Wed 8:30am)
JNJ: Get in Shape for Earnings Season: Coke, JPMorgan - at TheStreet.com (Wed 6:59am)
JNJ VRTX: Vertex partner begins late stage telaprevir trial - at Reuters (Wed 9:14am)
LLY: Lilly Launches New FORTEO Delivery Device - PR Newswire (Wed 8:00am)
WYE: Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder - PR Newswire (Wed 8:45am)
Comments